参考文献/References:
[1] He YD, Luo ZH, Yang M, et al. Prospective validation of DACH2 as a novel biomarker for prediction of metastasis and prognosi sin muscle-invasive urothelial carcinoma of the bladder[J]. Biochem Biophys Res Commun, 2015, 459(3): 416-423.
[2] Pickles MD, Gibbs P, Lowry M, et al, Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer[J]. Magn Rseon Imaging, 2006, 24(7): 843-847.
[3] Moffat BA, Chenevert TL, Lawrence TS, et al, Functional diffusoin map: a noninvasive MRI biomarker for early stratification of icnlica brain tumor response[J]. Proc Natl Acad Sci USA, 102(15): 5524-5529.
[4] Palou J, Algaba F, Vera I, et al. Protein expression patterns of ezrin are predictors of progression in T1G3 bladder tumours treated with nonmaintenance bacillus Calmette-Guérin[J]. Eur Urol, 2009, 56(5):829-836.
[5] van den Bosch S, Alfred Witjes J. Long-term Cancer-specific Survival in Patients with High-risk, Non-muscle-invasive Bladder Cancer and Tumour Progression: a systematic review[J]. Eur Urol ,2011, 60(3): 493-500.
[6] Cancer GN. Comprehensive molecular characterization of urothelial bladder carcinoma[J]. Nature, 2014, 507(7492): 315-322.
[7] 李辽源, 吴杰英, 刘绍远, 等. 膀胱尿路上皮癌组织中DACH2 的表达及临床意义[J/CD]. 中华腔镜泌尿外科杂志: 电子版, 2016,10(6): 45-48.
[8] Li LY, Yang M, Zhang HB, et al. Urinary fibronectin as a predtiocr of a residual tumour load after transurethral resection of bladder transitional cell carcinoma[J]. BJU Int, 2008, 102(5): 566-571.
[9] Matsuki M, Inada Y, Tatsugami F, et al. Diffusion-weighted Mr imaging for urinary bladder carcinoma: initial results[J]. Eur Radiol,2007, 17(1): 201-204.
[10] Qayyum A. Diffusion-weighted imaging in the abdomen and pelvis:concepts and applications[J]. Radiographics, 2009, 29(6): 17971-810.
[11] Panebianco V, Barchetti F, De Haas RJ, et al. Improving staging in bladder cancer: the increasing role of multiparametric magnteic resonance imaging[J]. Eur Urol Focus, 2016, 2(2): 113-121.
[12] Bagheri MH, Ahlman MA, Lindenberg L, et al. Advances in medical imaging for the diagnosis and management of common genitourinary cancers[J]. Urol Oncol, 2017, 35(7): 473-491.
[13] Lim KS, Tan CH. Diffusion-weighted MRI of adult male pelvic cancers[J]. Clin Radiol, 2012, 67(9): 899-908.
[14] Nakamura Y, Yoshida S, Tanaka H, et al. Potential utility of Diffusion-Weighted magnetic resonance imaging in diagnosis of residual bladder cancer before second transurethral resection[J]. Urol Int, 2017, 98(3): 298-303.
[15] Lee M, Shin SJ, Oh YT, et al. Non-contrast magnetic resonance imaging for bladder cancer: fused high b value diffusion-weighetd imaging and T2-weighted imaging helps evaluate depth of invasion[J]. Eur Radiol, 2017, 27(9): 3752-3758.
相似文献/References:
[1]袁晓亮,甘卫东,姚林方,等.荧光原位杂交技术在膀胱尿路上皮癌诊断中的临床应用[J].中华腔镜泌尿外科杂志(电子版),2012,(01):49.
YUAN Xiao-Hang,GAN Wei-dong,YAO Lin-fang,et al.The clinical application of flnoresence in situ hybridization in diagnosis of urothelial bladder cancer[J].,2012,(06):49.
[2]曹翔 甘卫东.Xp11.2 易位/TFE3 基因融合相关性肾细胞癌的认知[J].中华腔镜泌尿外科杂志(电子版),2014,(05):374.[doi:10.3877/cma.j.issn.1674-3253.2014.05.015
]
[3]李文标,谢俊聪,杨飞,等.尿流动力学检查在间质性膀胱炎/膀胱疼痛综合征诊断与症状评估中的应用[J].中华腔镜泌尿外科杂志(电子版),2017,11(04):268.[doi:10.3877/cma.j.issn.1674-3253.2017.04.013
]
Li Wenbiao,Xie Juncong,Yang Fei,et al.Clinical value of urodynamic testing in diagnosis and symptom assessment of IC/BPS patients[J].,2017,11(06):268.[doi:10.3877/cma.j.issn.1674-3253.2017.04.013
]
[4]许晖阳,王道虎,莫承强,等.囊性肾癌14例诊治体会并文献复习[J].中华腔镜泌尿外科杂志(电子版),2017,11(05):330.[doi:10.3877/cma.j.issn.1674-3253.2017.05.010
]
Xu Huiyang,Wang Daohu,Mo Chengqiang,et al.Experiences of diagnosis and treatment of cystic renal cell carcinoma with literature review: Report of 14 cases[J].,2017,11(06):330.[doi:10.3877/cma.j.issn.1674-3253.2017.05.010
]
[5]王邦郁,陈晓鹏,唐国军,等.尿液细胞外囊泡 circRNA 分类器对高级别前列腺癌诊断价值的初步研究[J].中华腔镜泌尿外科杂志(电子版),2023,17(04):339.
[6]李晓阳,刘柏隆,周祥福.大数据及人工智能对女性盆底功能障碍性疾病的诊断及风险预测[J].中华腔镜泌尿外科杂志(电子版),2023,17(06):549.[doi:10.3877/cma.j.issn.1674-3253.2023.06.001]
[J].,2023,17(06):549.[doi:10.3877/cma.j.issn.1674-3253.2023.06.001]